BIOREGATE

European Regenerative Medicine Forum

Nantes, France

Next edition in 2018

WHAT IS BIOREGATE FORUM?

bioregate-forum-400Bioregate Forum is a biennial European meeting dedicated to the “4R Medicine”: Repair, Replacement, Regeneration & Reprogramming. A regenerative medicine forum to highlight latest scientific, technological, clinical & commercialization approaches in the field of cell & gene therapy, stem cells, biomaterials and tissue engineering. Its vocation is to enhance links between researchers, clinicians, industrials and institutional stakeholders such as those responsible for regulation and reimbursement changes, and thus to shorten time to market for the patients’ benefits.

GREAT SUCCESS OF THE 1st EDITION - 8 & 9 SEPTEMBER 2016, NANTES, FRANCE

The 1st edition took place in Nantes september 2016 and featured conferences, roundtables, exhibition area, poster session and networking. A great opportunity to meet all the key innovative actors in the field of regenerative medicine and find collaborative partners!

Bioregate Forum 2018 will be held in Nantes. More information coming soon!

REGMED EUROPE - 7th July 2017 , PARIS, FRANCE

To continue the discussions initiated during Bioregate Forum 2016 we are glad to announce the first REGMED EUROPE event.

Organised by Medicen Cluster with european partners, this matchmaking event will gather companies, universities, research organizations and patients associations from Europe and beyond.

The topics will be Cell therapy, Gene therapy, Biomaterials and Tissue engineering.

The program includes conferences, networking and an entire session dedicated to B2B meetings.

Do not miss this chance to initiate R&D collaborations and to learn more on the next edition of Bioregate Forum 2018 !

REGISTER NOW ! 

More information on REGMED EUROPE 2017

Organising committee

Bioregate Forum is organized by Atlanpole Biotherapies and the University of Nantes (iPSC platform and Bioregate – the Regenerative Medicine Cluster in Western France).

It  is co-organized by the companies Hemarina and Clean Cells

Ask your questions :